Format

Send to

Choose Destination
Surg Clin North Am. 2014 Oct;94(5):989-1002, vii-viii. doi: 10.1016/j.suc.2014.07.003. Epub 2014 Aug 5.

Surviving cutaneous melanoma: a clinical review of follow-up practices, surveillance, and management of recurrence.

Author information

1
Department of Surgery, University of Texas Medical Branch, 301 University Boulevard, Route 0534, Galveston, TX 77555, USA.
2
Department of Surgery, University of Texas Medical Branch, 301 University Boulevard, Route 0737, Galveston, TX 77555, USA. Electronic address: cechao@utmb.edu.

Abstract

The number of melanoma survivors in the United States continues to steadily increase 2.6% per year, while death rates have remained stable over time. Although controversy exists regarding optimal surveillance strategies, recommendations for clinical monitoring are based on tumor stage, tumor phenotype, likelihood of recurrence, prognosis, risk factors, psychosocial impact of disease, and patient well-being. Management guidelines for recurrent disease depend on the type of recurrence: local, satellite/in-transit, regional, or distant metastasis. This article is a current review of the literature concerning melanoma survivorship.

KEYWORDS:

Management of recurrence; Melanoma survivorship; Surveillance and follow-up; Survival prognosis

PMID:
25245963
PMCID:
PMC4173121
DOI:
10.1016/j.suc.2014.07.003
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center